We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Several Cranberry Extracts Act to Prevent Infection by Reducing Bacterial Adhesion

By LabMedica International staff writers
Posted on 02 Aug 2016
Various chemical compounds have been isolated from cranberries and analyzed to determine their ability to prevent infection by reducing or eliminating adhesion of bacteria to biological surfaces.

Cranberry juice has been long used to in natural medicine to prevent infections because of its ability to prevent or reduce the adhesion of bacteria to the host surface. More...
Proanthocyanidins (PACs) comprise of one of the major classes of phytochemicals found in cranberry, which have been extensively studied and found effective in combating adhesion of pathogenic bacteria. The ability of other cranberry constituents to prevent bacterial adhesion remains to be determined.

Investigators at Worcester Polytechnic Institute (MA, USA) and the University of Massachusetts, Dartmouth (USA) used advanced atomic force microscopy techniques to evaluate the effect of various cranberry extracts on bacterial adhesion.

For this purpose the investigators used two strains of Escherichia coli: the pathogenic clinical bacterial strain E. coli B78 and the non-pathogenic control E. coli HB101. The preparations tested included crude cranberry juice extract (CCE); three fractions containing flavonoid classes including proanthocyanidins, anthocyanins and flavonols; selected sub-fractions, and the commercially available flavonol glycoside, quercetin-3-O-galactoside.

Results published in the May 13, 2016, online edition of the journal Food & Function revealed that adhesion forces of the non-pathogenic HB101 lab strain were small and did not change with cranberry treatments, whereas the adhesion forces of the pathogenic E. coli strain B78 showed a significant decrease when treated with cranberry juice extract or fractions. In particular, the fractions that contained flavonols in addition to PACs were more efficient at lowering the force of adhesion.

The sub-fractions containing flavonol glycosides (from juice, fruit, and commercial quercetin) all resulted in reduced adhesion of the pathogenic bacteria to the model probe. This strongly suggested that there was an anti-adhesive role for other classes of cranberry compounds in conjunction with already known PACs, and this finding may have implications for development of alternative anti-bacterial treatments.

"With the emergence of new superbugs that are resistant to current antibiotics, our hope is to better understand the mechanisms of bacterial infection so we can identify potential new antibiotic drug targets," said senior author Dr. Terri Camesano, professor of chemical engineering at Worcester Polytechnic Institute. ""This is an excellent collaboration that pairs what we do on the biophysical side at Worcester Polytechnic Institute with the work that University of Massachusetts, Dartmouth does on the biochemical side."

Related Links:
Worcester Polytechnic Institute
University of Massachusetts, Dartmouth

Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The Volition Nu.Q nucleosome assay runs on the IDS i10 automated analyzer platform (Photo courtesy of VolitionRx)

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes

Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.